Application of CMKLR1 micromolecule antagonist to control nonalcoholic fatty liver and hepatitis

A non-alcoholic, antagonistic technology, applied in the direction of anti-inflammatory agents, amine active ingredients, non-central analgesics, etc., can solve the problems of long time and achieve low cost, good market application prospects, and simple synthesis

Inactive Publication Date: 2015-03-25
SHENZHEN INST OF ADVANCED TECH
View PDF1 Cites 27 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

but it takes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of CMKLR1 micromolecule antagonist to control nonalcoholic fatty liver and hepatitis
  • Application of CMKLR1 micromolecule antagonist to control nonalcoholic fatty liver and hepatitis
  • Application of CMKLR1 micromolecule antagonist to control nonalcoholic fatty liver and hepatitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Application of CMKLR1 small molecule antagonist in preventing and treating non-alcoholic fatty liver and hepatitis; the CMKLR1 small molecule antagonist is α-NETA and its derivatives.

[0031] The non-alcoholic fatty liver and hepatitis are fatty liver and hepatitis caused by high energy diet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of a CMKLR1 micromolecule antagonist to control nonalcoholic fatty liver and hepatitis. The application of the CMKLR1 micromolecule antagonist to control nonalcoholic fatty liver and hepatitis is proved according to the following steps: employing alpha-NETA with different concentration to intervene a nonalcoholic fatty liver in-vitro model, and performing result detection; and employing alpha-NETA with a quantitative concentration to intervene a nonalcoholic fatty liver in-vivo model, detecting acquired tissue. The CMKLR1 micromolecule antagonist is capable of specifically antagonizing GPCR receptor ChemR23, and provides a new tool for medicines treating nonalcoholic fatty liver or fatty liver hepatitis. The CMKLR1 micromolecule antagonist is relatively simple in synthesis and relatively low in cost, and has extremely good market application prospect on control of nonalcoholic fatty liver and hepatitis.

Description

【Technical field】 [0001] The invention belongs to the technical field of biomedicine, and particularly relates to the application of CMKLR1 small molecule antagonist in preventing and treating non-alcoholic fatty liver and hepatitis. 【Background technique】 [0002] With the growth of social economy and the continuous improvement of diet structure and living standards, metabolic syndrome caused by excessive dietary nutrition is also increasing. Metabolic syndrome refers to a group of diseases related to metabolic disorders caused by excess energy in the body. Its three major energy-producing substances cannot effectively generate energy and cause excessive storage, such as excessive sugar conversion into glycogen or fat, resulting in cell storage pools Saturation, then insulin resistance and diabetes appear; when the lipid storage is in a saturated state, obesity, fatty liver and cholesterol-related diseases, such as coronary heart disease and atherosclerosis, will appear. A...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/14A61P1/16A61P29/00
CPCA61K31/14
Inventor 张键穆淑花张旭
Owner SHENZHEN INST OF ADVANCED TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap